Medical ointment for treating chronic atrophic gastritis by plastering and applying on acupuncture point

Abstract

The invention relates to a medical ointment for treating chronic atrophic gastritis with acupoint application, which solves the treating problem of chronic atrophic gastritis. The medical ointment is made by astragalus root, campanumaea pilosula, Dendrobium nobile, radix salvia miltiorrhiza, Cinnamomum cassia, beach silvertop root, black plum, citrus fruit, baras camphor, anhydrous adeps lanae, nitrogen ketone and white petrolatum. The preparing method comprises the following steps: disintegrating Cinnamomum cassia; getting aqua aromatic and volatile oil by distilling; getting the extract by reflux-extracting with alcohol and evaporating radix salvia miltiorrhiza; getting the liquid machine by heating, refluxing and extracting astragalus root with alcohol; boiling, depositing with alcohol and evaporating campanumaea pilosula, Dendrobium nobile, radix salvia miltiorrhiza, Cinnamomum cassia and beach silvertop root; getting the extract and merging the above four drugs; adding and mixing anhydrous adeps lanae, baras camphor and white petrolatum; adding nitrogen ketone; getting the medical ointment for treating chronic atrophic gastritis with acupoint application. The invention has the good treatment effect, the high efficient, the low fee, the convenient and safe treatment, which provides creative contribution for treating chronic atrophic gastritis, and makes good fortune for human.

Description

1. Technical field [0001] The invention relates to the field of medicine, in particular to an acupoint sticking ointment for treating chronic atrophic gastritis. 2. Background technology [0002] Chronic atrophic gastritis (also referred to as CAG, hereinafter the same) is one of the common frequently-occurring and refractory diseases of the digestive system, and is closely related to the occurrence of gastric cancer. In 1978, the World Health Organization listed chronic atrophic gastritis with intestinal metaplasia and gastric mucosal dysplasia as a precancerous disease or precancerous state of gastric cancer, which is one of the focuses of current research in the digestive field. Literature reports that CAG with intestinal epithelium The canceration rate of metaplasia patients was 1.9%, and the canceration rates of patients with mild, moderate and severe dysplasia were 2.5-11%, 4-35% and 10-83%, respectively. Chronic atrophic gastritis has a high incidence rate, a long co...

AI Technical Summary

Problems solved by technology

It is worth noting that in the anti-Hp infection therapy, there are obvious side effects such as nausea, fatigue, dizziness, anorexia, etc. Drug-induced secondary drug resistance, so the eradication rate of drug-resistant Hp strains is low, and those who fail to eradicate cannot be reused, and after being widely used, the drug resistance rate will increase year by year

Although there are many drugs for the treatment of CAG in modern medicine, there has been no breakthrough report so far

The effect of treating chronic atrophic gastritis is not satisfactory, therefore, it is imperative to develop new ways to treat chronic atrophic gastritis